PGD and cancer: The combined treatment with the 6PGD inhibitor Physcion and cisplatin showed a selective synergistic effect on cisplatin-resistant cells, suggesting that upregulation of 6PGD activity could be a promising targetable mechanism underlying cisplatin resistance in cancer cells.